Skip to main content

Table 1 The basic characteristics of the included studies

From: Imaging findings and clinical relevance of 68Ga-Pentixafor PET in atherosclerosis: a systematic review

Author

Year

The country of the subject

Prospective

Age

BMI

(kg/m2)

Time

interval

Subject population

CRF

Patients

(M/F)

Imaging device

Lu [9]

2022

Austria

a

N

68 ± 10

27.1

1 W

Lymphoma

Smoking, Hypertension,

Dyslipidemia,

Diabetes, CRP(≥ 3 mg/L)

19(11/8)

PET/

MRI

Lawal  [10]

2020

SouthAfrica

Y

44.67 ± 7.62

24.18 ± 3.45

2 D

HIV-infected

Smoking, Hypertension,

Diabetes,

Family history of CVD

12(4/8)

PET/

CT

Kircher  [11]

2020

Germany

N

62 ± 10

26

3 D

Multiple Myeloma

Adrenocortical Cancer

Neuroendocrine Tumour

Non-Small Cell Lung Cancer

Pleuramesothelioma

Lymphoma

Stomach Cancer

Hepatocellulary-Carcinoma

T-Cell Non-Hodgkin Lymphoma

Small Cell Lung Cancer

Pancreatic Cancer

Thyroid Cancer

Diffuse Large B-cell Lymphoma

Smoking, Hypertension,

Diabetes, CRP(≥ 3 mg/L),

Obesity, History of CVD

92(55/37)

PET/

CT

Li  [12]

2019

Austria

China

Y

61.8 ± 12.7

26.8 ± 4.0

NR

Mucosa-associated lymphoid tissue (MALT) lymphoma

Smoking, Hypertension,

Dyslipidemia, Diabetes

72(45/27)

PET/

MRI

Li  [13]

2018

NR

Y

67 ± 11

26 ± 4

3 W

Lymphoma

Pancreatic cancer

Smoking, Hypertension,

Dyslipidemia, Diabetes,

Family history of CVD,

History of CVD

34(17/17)

PET/

MRI

Weiberg  [14]

2018

Germany

N

59.5 ± 16.2

NR

NR

Interstitial lung disease

Sarcoidosis

Complicated urinary tract infection

Leukemia

Miscellaneous

Smoking, Hypertension,

Dyslipidemia, Diabetes,

History of CVD

51(39/12)

PET/

CT

  1. N no, Y yes, D day, W week, M male, F female, CRF Cardiovascular Risk Factors, CVD Cardiovascular Disease, CRP C−reactive protein, HIV Human immunodeficiency virus